Fri. 1 Mar 2024, 6:02am ET
Benzinga
Earnings, News
Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 71.43 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $14.67 million which missed the analyst consensus estimate of $15.61 million by 6.03 percent. This is a 98.38 percent decrease over sales of $908.00 million the same period last year.